177 related articles for article (PubMed ID: 31068366)
1.
Xu C; Ooi WF; Qamra A; Tan J; Chua BY; Ho SWT; Das K; Adam Isa ZF; Li Z; Yao X; Yan T; Xing M; Huang KK; Lin JS; Nandi T; Tay ST; Lee MH; Tan ALK; Ong X; Ashktorab H; Smoot D; Li S; Ng SC; Teh BT; Tan P
Gut; 2020 Feb; 69(2):231-242. PubMed ID: 31068366
[TBL] [Abstract][Full Text] [Related]
2. HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer.
Chang HR; Nam S; Kook MC; Kim KT; Liu X; Yao H; Jung HR; Lemos R; Seo HH; Park HS; Gim Y; Hong D; Huh I; Kim YW; Tan D; Liu CG; Powis G; Park T; Liang H; Kim YH
Gut; 2016 Jan; 65(1):19-32. PubMed ID: 25410163
[TBL] [Abstract][Full Text] [Related]
3. Regulatory crosstalk between lineage-survival oncogenes KLF5, GATA4 and GATA6 cooperatively promotes gastric cancer development.
Chia NY; Deng N; Das K; Huang D; Hu L; Zhu Y; Lim KH; Lee MH; Wu J; Sam XX; Tan GS; Wan WK; Yu W; Gan A; Tan AL; Tay ST; Soo KC; Wong WK; Dominguez LT; Ng HH; Rozen S; Goh LK; Teh BT; Tan P
Gut; 2015 May; 64(5):707-19. PubMed ID: 25053715
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.
Tanaka T; Jiang S; Hotta H; Takano K; Iwanari H; Sumi K; Daigo K; Ohashi R; Sugai M; Ikegame C; Umezu H; Hirayama Y; Midorikawa Y; Hippo Y; Watanabe A; Uchiyama Y; Hasegawa G; Reid P; Aburatani H; Hamakubo T; Sakai J; Naito M; Kodama T
J Pathol; 2006 Apr; 208(5):662-72. PubMed ID: 16400631
[TBL] [Abstract][Full Text] [Related]
5. Mutual amplification of HNF4α and IL-1R1 composes an inflammatory circuit in Helicobacter pylori associated gastric carcinogenesis.
Ma L; Zeng J; Guo Q; Liang X; Shen L; Li S; Sun Y; Li W; Liu S; Yu H; Chen C; Jia J
Oncotarget; 2016 Mar; 7(10):11349-63. PubMed ID: 26870992
[TBL] [Abstract][Full Text] [Related]
6. Intelectin 1 suppresses tumor progression and is associated with improved survival in gastric cancer.
Li D; Zhao X; Xiao Y; Mei H; Pu J; Xiang X; Jiao W; Song H; Qu H; Huang K; Zheng L; Tong Q
Oncotarget; 2015 Jun; 6(18):16168-82. PubMed ID: 25965823
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
Takano K; Hasegawa G; Jiang S; Kurosaki I; Hatakeyama K; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma.
Yao HS; Wang J; Zhang XP; Wang LZ; Wang Y; Li XX; Jin KZ; Hu ZQ; Wang WJ
Mol Carcinog; 2016 May; 55(5):458-72. PubMed ID: 25808746
[TBL] [Abstract][Full Text] [Related]
9. Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer.
Chang HR; Nam S; Lee J; Kim JH; Jung HR; Park HS; Park S; Ahn YZ; Huh I; Balch C; Ku JL; Powis G; Park T; Jeong JH; Kim YH
Oncotarget; 2016 Dec; 7(49):81435-81451. PubMed ID: 27806312
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte nuclear factor 4α regulates the expression of the murine pyruvate carboxylase gene through the HNF4-specific binding motif in its proximal promoter.
Chavalit T; Rojvirat P; Muangsawat S; Jitrapakdee S
Biochim Biophys Acta; 2013 Oct; 1829(10):987-99. PubMed ID: 23665043
[TBL] [Abstract][Full Text] [Related]
11. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P
Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375
[TBL] [Abstract][Full Text] [Related]
12. Weighted gene co-expression network analysis and connectivity map identifies lovastatin as a treatment option of gastric cancer by inhibiting HDAC2.
Zhang L; Kang W; Lu X; Ma S; Dong L; Zou B
Gene; 2019 Jan; 681():15-25. PubMed ID: 30266498
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis signal-regulating kinase 1 mediates the inhibitory effect of hepatocyte nuclear factor-4α on hepatocellular carcinoma.
Jiang CF; Wen LZ; Yin C; Xu WP; Shi B; Zhang X; Xie WF
Oncotarget; 2016 May; 7(19):27408-21. PubMed ID: 27050273
[TBL] [Abstract][Full Text] [Related]
14. A high resolution genome-wide scan of HNF4α recognition sites infers a regulatory gene network in colon cancer.
Weltmeier F; Borlak J
PLoS One; 2011; 6(7):e21667. PubMed ID: 21829439
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte nuclear factor 4α is required for cell differentiation and homeostasis in the adult mouse gastric epithelium.
Moore BD; Khurana SS; Huh WJ; Mills JC
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G267-75. PubMed ID: 27340127
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte nuclear factor-4alpha promotes gut neoplasia in mice and protects against the production of reactive oxygen species.
Darsigny M; Babeu JP; Seidman EG; Gendron FP; Levy E; Carrier J; Perreault N; Boudreau F
Cancer Res; 2010 Nov; 70(22):9423-33. PubMed ID: 21062980
[TBL] [Abstract][Full Text] [Related]
17. P1 promoter-driven HNF4α isoforms are specifically repressed by β-catenin signaling in colorectal cancer cells.
Babeu JP; Jones C; Geha S; Carrier JC; Boudreau F
J Cell Sci; 2018 Jul; 131(13):. PubMed ID: 29898915
[TBL] [Abstract][Full Text] [Related]
18. Targeting IDH1-Mutated Malignancies with NRF2 Blockade.
Liu Y; Lu Y; Celiku O; Li A; Wu Q; Zhou Y; Yang C
J Natl Cancer Inst; 2019 Oct; 111(10):1033-1041. PubMed ID: 30759236
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
[TBL] [Abstract][Full Text] [Related]
20. Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth.
Ye J; Huang Q; Xu J; Huang J; Wang J; Zhong W; Chen W; Lin X; Lin X
J Cancer Res Clin Oncol; 2018 May; 144(5):821-833. PubMed ID: 29435734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
